Danish scientists uncovered compelling evidence that a significant percentage of the batches of the Pfizer-BioNTech COVID-19 vaccine distributed in the EU likely consisted of placebos — and the non-placebo batches demonstrated higher-than-normal severe adverse events in recipients, prompting the researchers to call for further investigation
Why would Pfizer want Paxlovid licensed anyway, when it made a huge profit selling it to the USG as an EUA? Presumably it hopes to sell a lot more, and maybe Uncle Sam didn’t want to spend billions buying more
Australia has opened the doors to a vaccine skin patch manufacturing facility in hopes to reduce the complexities and costs associated with existing vaccines and be better position the country for future pandemics
The World Health Organization’s cancer research agency has analyzed the potential carcinogenic effects of aspartame, one of the world’s most popular artificial sweeteners, and health officials said they will soon update its risk assessment
Now that the pandemic has ended, researchers are urging regulatory agencies to consider the safety issues associated with the rapid approval of COVID-19 vaccines—and to correctly classify messenger RNA (mRNA) vaccines as gene therapy products (GTPs) to prevent pharmaceutical companies from bypassing regulatory standards
Over the course of the COVID-19 crisis we have heard from government officials and those supporting the mass vaccination campaign that the CDC Vaccine Adverse Event System (VAERS) is not reliable and that patient/family/healthcare provider reports into the system may not be accurate and thus cannot be used to assess causality